3D-QSAR and molecular docking studies of ATP-competitive Akt inhibitors with the scaffold 4-(piperazin-1-yl)pyrimidine. Chemical Biology Letters, [S. l.], v. 1, n. 2, p. 44–54, 2014. Disponível em: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/114.. Acesso em: 6 may. 2024.